Consult the medical resource doctors trust
UpToDate is one of the most respected medical information resources in the world, used by over 360,000 doctors and thousands of patients to find answers to medical questions.
Related articles
![]() | Preview Available (subscription required for full access) |










| AuthorDavid A Peura, MD | Section EditorMark Feldman, MD | Deputy EditorsLeah K Moynihan, RNC, MSNCarla H Ginsburg, MD, MPH, AGAF |
Contents of this article
Helicobacter pylori, also known as H. pylori, is a bacterium that is commonly found in the stomach. It is present in approximately one-half of the world's population.
The vast majority of people infected with H. pylori infection have no symptoms and will never develop problems. However, H. pylori is capable of causing a number of digestive problems, including ulcers, and, much less commonly, stomach cancer. It is not clear why some people with H. pylori get these conditions and others do not.
This article discusses the symptoms, testing, and treatment of Helicobacter pylori infections. Stomach ulcers, also known as peptic ulcers, are discussed separately. (See "Patient information: Peptic ulcer disease".)
H. pylori is probably spread by consuming food or water contaminated with fecal matter. H. pylori causes changes to the stomach and duodenum (the first part of the small intestine, (figure 1). The bacteria invades the protective tissue that lines the stomach. This leads to the release of certain enzymes and toxins. These enzymes and toxins may directly or indirectly injure the cells of the stomach or duodenum.
As a result of these changes, the stomach and duodenum are more vulnerable to damage from digestive juices, such as stomach acid. This causes chronic inflammation in the walls of the stomach (gastritis) or duodenum (duodenitis).
In the United States and other developed countries, infection with H. pylori is unusual during childhood but becomes more common during adulthood. However, in developing countries, most children are infected with H. pylori before age 10.
Most individuals with chronic gastritis or duodenitis have no symptoms. However, some people develop more serious problems, including stomach or duodenal ulcers.
Ulcers can cause a variety of symptoms or no symptoms at all, with the most common ulcer symptoms including:
Less commonly, chronic gastritis causes abnormal changes in the stomach lining, which can lead to certain forms of cancer. It is uncommon to develop cancer as a result of H. pylori infection. Nevertheless, because so many people in the world are infected with H. pylori, it is considered to be an important cause of stomach cancer. People who live in countries in which H. pylori infection occurs at an early age are at greatest risk of stomach cancer.
There are several ways to diagnose H. pylori. The most commonly used tests include the following:
Blood tests — Blood tests can detect specific antibodies (proteins) that the body's immune system develops in response to the H. pylori bacterium.
Breath tests — Breath tests (known as urea breath tests) require that you drink a specialized solution containing a substance that is broken down by the H. pylori bacterium. The breakdown products can be detected in your breath.
Stool tests — Tests are available that detect H. pylori proteins in stool.
WHO SHOULD BE TESTED FOR H. PYLORI?
If you have symptoms — Diagnostic testing for Helicobacter pylori infection is recommended if you have active gastric or duodenal ulcers or if you have a past history of ulcers.
Although H. pylori infection is the most common cause of ulcers, not all patients with ulcers have H. pylori. Certain medications (eg, aspirin, ibuprofen (Motrin®, Advil®), naproxen (Aleve®)) can also cause peptic ulcers. (See "Patient information: Peptic ulcer disease".)
If you do not have symptoms — H. pylori testing is usually not recommended if you have no symptoms and no past history of peptic ulcer disease. However, it may be considered for selected people, such as those with a family history or concern about stomach cancer, particularly individuals of Chinese, Korean, or Japanese descent; these groups have a higher incidence of stomach cancer.
People with a history of peptic ulcer disease, active gastric ulcer, or active duodenal ulcer associated with H. pylori infection should be treated. Successful treatment of H. pylori can help the ulcer to heal, prevent ulcers from coming back, and reduce the risk of ulcer complications (like bleeding).
Medications — No single drug cures Helicobacter pylori infection. Treatment involves taking several medications for 7 to 14 days.
Although the optimal H. pylori treatment regimen continues to be investigated, the American College of Gastroenterology has recommended four specific drug regimens that use a combination of at least three medications (table 1). These regimens successfully cure infection in up to 90 percent of people. For the H. pylori treatment to be effective, it is important to take the entire course of all medications.
Side effects — Up to 50 percent of patients have side effects while taking H. pylori treatment. Side effects are usually mild, and fewer than 10 percent of patients stop treatment because of side effects. For those who do experience side effects, it may be possible to make adjustments in the dose or timing of medication. Some of the most common side effects are described below.
Treatment failure — Up to 20 percent of patients with Helicobacter pylori infection are not cured after completing their first course of treatment. A second treatment regimen is usually recommended in this case. Retreatment usually requires that the patient take 14 days of a proton pump inhibitor and two antibiotics. At least one of the antibiotics is different from those used in the first treatment course.
Follow up — After completing H. pylori treatment, repeat testing is usually performed to ensure that the infection has resolved. This is typically done with a breath or stool test (see 'Breath tests' above. Blood tests are not recommended for follow up testing; the antibody detected by the blood test often remains in the blood for four or more months after treatment, even after the infection is eliminated.
Your healthcare provider is the best source of information for questions and concerns related to your medical problem. Because no two people are exactly alike and recommendations can vary from one person to another, it is important to seek guidance from a provider who is familiar with your individual situation.
This discussion will be updated as needed every four months on our web site (www.uptodate.com/patients). Additional topics as well as selected discussions written for healthcare professionals are also available for those who would like more detailed information.
Some of the most pertinent include:
Patient Level Information:
Patient information: Peptic ulcer disease
Professional Level Information:
Acute and chronic gastritis due to Helicobacter pylori
Association between Helicobacter pylori infection and duodenal ulcer
Association between Helicobacter pylori infection and gastrointestinal malignancy
Bacteriology and epidemiology of Helicobacter pylori infection
Helicobacter pylori and gastroesophageal reflux disease
Helicobacter pylori-negative peptic ulcer disease
Indications and diagnostic tests for Helicobacter pylori infection
Management of duodenal ulcers in patients infected with Helicobacter pylori
Overview of the natural history and treatment of peptic ulcer disease
Treatment regimens for Helicobacter pylori
A number of web sites have information about medical problems and treatments, although it can be difficult to know which sites are reputable. Information provided by the National Institutes of Health, national medical societies and some other well-established organizations are often reliable sources of information, although the frequency with which they are updated is variable.
(www.nlm.nih.gov/medlineplus/healthtopics.html)
[1-4]
| References |
Top
|
UpToDate performs a continuous review of over 430 journals and other resources. Updates are added as important new information is published. The literature review for version 17.3 is current through September 2009; this topic was last changed on June 2, 2009. The next version of UpToDate (18.1) will be released in March 2010.
![]() |
Please wait |